📰 Mdx Testing Services News
Page 4 - Mdx Testing Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mdx Testing Services. Real-time updates on events, politics, business and more.
December 31, 2023
Intertek Group (OTCMKTS:IKTSY – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Profitability This table compares Intertek Group […]
December 29, 2023
Digipath (OTCMKTS:DIGP – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk. Institutional & Insider Ownership 17.3% of Applied […]
December 29, 2023
Digipath (OTCMKTS:DIGP – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 17.3% of Applied […]
December 27, 2023
NeoGenomics (NASDAQ:NEO – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations. Earnings & Valuation This table compares NeoGenomics and […]
December 25, 2023
Digipath (OTCMKTS:DIGP – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends. Valuation and Earnings This table compares Digipath […]
December 23, 2023
Digipath (OTCMKTS:DIGP – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership. Analyst Ratings This is a breakdown of […]
December 19, 2023
NeoGenomics (NASDAQ:NEO – Get Free Report) and Applied DNA Sciences (NASDAQ:APDN – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends. Valuation and Earnings This table compares NeoGenomics and […]
December 11, 2023
StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $4.00 target price on shares of Applied DNA Sciences in a research […]
December 9, 2023
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) announced its quarterly earnings results on Thursday. The technology company reported ($0.26) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.01, MarketWatch Earnings reports. The company had revenue of $0.78 million during the quarter, compared to the consensus estimate of $1.60 million. […]
December 2, 2023
StockNews.com initiated coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a report issued on Wednesday. The firm issued a hold rating on the technology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $4.00 price target on shares of Applied DNA Sciences in a research note on Thursday, […]